. 2022 Jun 29;7(27):23566–23575. doi: 10.1021/acsomega.2c02102

Table 3. Activities of AAMPSS, PRPP, GAPDH, and SCS Enzymes under Different Treatments.

	AMPSS	PRPP	PRPPAT	SCS	GAPDH
treatment	U L^–1
CK	288.96^d	210.15^c	116^e	205.24^e	154.25^b
P100%	292.05^d	222.38^b	139^d	295.08^c	114.45^d
CP100%	336.94^c	156.46^h	155^b	258.11^d	166.76^a
P100%Z	405.39^a	183.65^d	163^a	301.48^b	101.51^e
P80%Z	405.39^a	171.41^e	161^a	301.28^b	143.29^c
CP100%Z	346.76^b	238.69^a	145^c	312.22^a	154.80^b
CP80%Z	350.12^b	223.40^b	156^b	196.56^f	145.70^c

Note: AMPSS, adenylosuccinate synthase; PRPP, phosphoribosyl pyrophosphate; SCS, succinyl coenzyme A synthetase; and GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Means followed by similar lowercase letters within the same column of each item were not significant in the difference at the 5% level.